© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Aurelius Germany Acquisition of Regain Polymers
Posted 31st July 2015

Aurelius Germany Acquisition of Regain Polymers

Aurelius Germany Acquisition of Regain Polymers

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Aurelius Germany Acquisition of Regain Polymers

Aurelius Germany Acquisition of Regain Polymers

Aurelius Group (ISIN DE000A0JK2A8) (“Aurelius”), the pan-European, mid-market investor, today announces its acquisition of Regain Polymers Holdings Limited (“Regain” or “the Company”) from Chamonix Private Equity for an undisclosed sum.

Regain is the UK’s leading bespoke compounder and recycler of post-use, rigid plastics. Founded in 1991, it operates from a single well-invested site at Allerton Bywater, near Castleford, Yorkshire. Regain reported turnover of £31m in 2014 and employs over 100 people.

Regain has a strong track record in the extrusion of recycled rigid plastics tailored to the exact specification of its customers, which include operators in the automotive, environmental, horticultural, packaging and construction markets. The Company’s broad product portfolio spans the High Density Polyethylene (HDPE), Polypropylene (PP), Talc-Filled Polypropylene (PPT) and Polystyrene (PS) polymers. Its current compounding capacity across seven extrusion lines is approximately 46,000 MT per annum; the Company currently operates two wash plants and a material preparation facility with a capacity of 28,000 MT per annum, allowing it to remove contaminants, paper, metal and dirt prior to reprocessing.

Dirk Markus, Chief Executive of Aurelius Group commented: “We are very pleased to be announcing this deal which adds a further plastics recycling business to our portfolio. This positive partnership between Aurelius and Regain will create a strong commercial platform to support the Company’s current operations and longer-term strategic development. Aurelius has a strong track record in supporting growth and value creation in its investee companies.

This, combined with our focus on operational improvement and experience in the plastics space, positions the Aurelius team very well to support the organic growth of Regain going forward.” Tristan Nagler, Managing Director of Aurelius UK, added: “Regain is a robust and innovative business which has successfully met the evolving requirements of its clients for increasingly complex, technical and cost-effective compounding solutions with guaranteed end product quality. We look forward to working with the Regain management team to further develop the Company’s market leading offering to take advantage of the growing demand for recycled content in plastics applications from retailers, brand owners and automotive OEMs looking to reduce the carbon impact of packaging and products.”

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Alamos Gold, AuRico Gold merging in $1.5 billion deal
Finance
15/04/2015Alamos Gold, AuRico Gold merging in $1.5 billion deal

Canadian gold mining companies Alamos Gold and AuRico Gold Inc. are merging in a deal valued at approximately $1.5 billion.

Read Full PostRead - Eye Icon
5 Resources to Help You Find a Knowledgeable Personal Injury Lawyer in Atlanta
Legal
13/05/20245 Resources to Help You Find a Knowledgeable Personal Injury Lawyer in Atlanta

After an incident, the aftermath entails stress and chaos. If involved in a car accident, for example, you’re already dealing with injuries, damage to your automobile, and intricacies involved.

Read Full PostRead - Eye Icon
The Desire to Acquire & The Urge to Merge
M&A
26/11/2015The Desire to Acquire & The Urge to Merge

de Marcellus & Disser specialises in IP law and assisting companies involved in IP law surrounding M&A activity.

Read Full PostRead - Eye Icon
Mid Market Top 50
Innovation
02/06/2016Mid Market Top 50

Novimmune is a privately held Swiss bio-pharmaceutical company focused on the discovery, development and commercialisation of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.

Read Full PostRead - Eye Icon
How to Lower Your Car Insurance Payments Fast
Finance
12/01/2023How to Lower Your Car Insurance Payments Fast

Everyone would like to lower the cost of their car insurance payments. However, not everybody actually looks at active ways to reduce the cost of their auto insurance. If that’s you, it’s time to change your ways. So, check out the following helpful advice

Read Full PostRead - Eye Icon
5 Urbanisation Challenges That Could Be Easily Handled by AI
Innovation
08/11/20225 Urbanisation Challenges That Could Be Easily Handled by AI

The world is moving faster than ever with billions of people on the move. In fact, by 2050, more than two-thirds of the global population will live in cities.

Read Full PostRead - Eye Icon
8 Ways Retail Exhibitions Help Brands Gauge Market Readiness
News
08/08/20258 Ways Retail Exhibitions Help Brands Gauge Market Readiness

Bringing a product to market comes with a mix of ambition and risk. Even with detailed planning, brands can face uncertainty around how their offer will perform once it meets real-world conditions. Retail exhibitions provide access to decision-makers, buyers,

Read Full PostRead - Eye Icon
State-Of-The-Science Environmental IT Solutions
Innovation
16/10/2019State-Of-The-Science Environmental IT Solutions

Having recently been recognized by AI as the Best Specialist Environmental Software Solutions Firm 2019 – Ontario, we profiled Lakes Software and caught up with the firm’s Bryan Matthews (US Operations Manager) who provided us with a glimpse into the inner

Read Full PostRead - Eye Icon
Government Order Fixes the Rights of UK Nationals Continuing to Stay in France
Legal
23/07/2019Government Order Fixes the Rights of UK Nationals Continuing to Stay in France

The French government published an order which determines the right of UK nationals continuing to stay in France after the Brexit date of 29 March 2019, in the most probable event of no exit agreement being reached between the UK and the EU.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow